Utrecht Summer School logo
2017
Utrecht University logo

Pharmaceutical Policy Analysis

Organizing institution
Utrecht University, Faculty of Science (UU)
Course code
M7
Course fee (incl. housing)
€ 1150
Level
Advanced master level

This course will give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide lecturers for several of the sessions.

Medicines are among the most regulated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of pharmacotherapy. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Furthermore, the inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place.

The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.

You will experience an intensive programme covering the following topics:
Pharmaceutical Policy Analysis issues and methods; current challenges in drug innovation; universal health coverage; regulatory issues and challenges; country profiles; policy and politics; synthesis, case studies & public health.

Tags: medicines, policies, regulation, pharmacy, who, access, methodology, public health

» Download the day-to-day programme (PDF)

Bookmark and Share

COURSE LEADER

Dr. Aukje Mantel-Teeuwisse

LECTURERS

Prof. Dr. Bert Leufkens, Dr. Gilles Forte (WHO), Dr. Aukje Mantel-Teeuwisse and other UU and WHO staff members.

TARGET GROUP

(Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge public health/medicine who have an interest in the policy aspects of pharmaceuticals, pharmacoepidemiology and/or pharmacoeconomics.

COURSE AIM

The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.

STUDY LOAD

1 week full time

FEE

• € 1150 - Course + course materials + housing
• € 950 - Course + course materials

The fee includes lunches and one course dinner.

This course can be combined with course M8 (Pharmacoepidemiology & Drug Safety) and/or M14 (Pharmacoeconomics). Combination fee for two courses is 1500,- (excluding housing), combination fee for all three courses combined is 1950,- (excluding housing).

Please note: the deadline for registration is June, 8th 2017. However, we are working with a waiting list since we are already fully booked. If you are still interested in this course, please apply and the course assistent will contact you about your position on the waiting list.

DISCOUNTS AND COMBINATIONS
» Overview of all available discounts

The course Pharmaceutical Policy Analysis can be combined with the following courses.

SCHOLARSHIPS

Utrecht Summer School doesn't offer scholarships for this course.

MORE INFORMATION

Dr. Rianne van den Ham
P: +31 6 22 73 59 84
E: h.a.vandenham@uu.nl

» Contact Utrecht Summer School

REGISTRATION

Deadline for registration: 08 June 2017